nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—TAP1—midbrain—nicotine dependence	0.0454	0.117	CbGeAlD
Lapatinib—PIK3C2B—midbrain—nicotine dependence	0.0427	0.109	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—nicotine dependence	0.0425	0.109	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—nicotine dependence	0.0425	0.109	CbGeAlD
Lapatinib—ERBB4—midbrain—nicotine dependence	0.0332	0.0851	CbGeAlD
Lapatinib—PI4KB—midbrain—nicotine dependence	0.0311	0.0797	CbGeAlD
Lapatinib—TAP1—brain—nicotine dependence	0.0286	0.0732	CbGeAlD
Lapatinib—PIK3C2B—brain—nicotine dependence	0.0268	0.0688	CbGeAlD
Lapatinib—ERBB2—brain—nicotine dependence	0.0208	0.0535	CbGeAlD
Lapatinib—ERBB4—brain—nicotine dependence	0.0208	0.0535	CbGeAlD
Lapatinib—PI4KB—brain—nicotine dependence	0.0195	0.0501	CbGeAlD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0194	0.0862	CbGpPWpGaD
Lapatinib—EGFR—brain—nicotine dependence	0.0177	0.0453	CbGeAlD
Lapatinib—Renal failure acute—Varenicline—nicotine dependence	0.0166	0.0431	CcSEcCtD
Lapatinib—Hot flush—Varenicline—nicotine dependence	0.0164	0.0426	CcSEcCtD
Lapatinib—Menopausal symptoms—Varenicline—nicotine dependence	0.0162	0.0422	CcSEcCtD
Lapatinib—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0146	0.0649	CbGpPWpGaD
Lapatinib—Dry skin—Varenicline—nicotine dependence	0.014	0.0365	CcSEcCtD
Lapatinib—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0131	0.058	CbGpPWpGaD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0121	0.0537	CbGpPWpGaD
Lapatinib—Infestation NOS—Varenicline—nicotine dependence	0.0118	0.0307	CcSEcCtD
Lapatinib—Infestation—Varenicline—nicotine dependence	0.0118	0.0307	CcSEcCtD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0116	0.0514	CbGpPWpGaD
Lapatinib—Stomatitis—Varenicline—nicotine dependence	0.0115	0.0299	CcSEcCtD
Lapatinib—Hepatobiliary disease—Varenicline—nicotine dependence	0.0112	0.029	CcSEcCtD
Lapatinib—Epistaxis—Varenicline—nicotine dependence	0.0111	0.0289	CcSEcCtD
Lapatinib—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0105	0.0465	CbGpPWpGaD
Lapatinib—Connective tissue disorder—Varenicline—nicotine dependence	0.0104	0.0271	CcSEcCtD
Lapatinib—Cardiac disorder—Varenicline—nicotine dependence	0.00983	0.0256	CcSEcCtD
Lapatinib—Angiopathy—Varenicline—nicotine dependence	0.00961	0.025	CcSEcCtD
Lapatinib—Immune system disorder—Varenicline—nicotine dependence	0.00957	0.0249	CcSEcCtD
Lapatinib—Mediastinal disorder—Varenicline—nicotine dependence	0.00955	0.0248	CcSEcCtD
Lapatinib—Mental disorder—Varenicline—nicotine dependence	0.00928	0.0241	CcSEcCtD
Lapatinib—Malnutrition—Varenicline—nicotine dependence	0.00922	0.024	CcSEcCtD
Lapatinib—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00908	0.0403	CbGpPWpGaD
Lapatinib—Back pain—Varenicline—nicotine dependence	0.00892	0.0232	CcSEcCtD
Lapatinib—Anaemia—Varenicline—nicotine dependence	0.00852	0.0222	CcSEcCtD
Lapatinib—Palpitations—Varenicline—nicotine dependence	0.00815	0.0212	CcSEcCtD
Lapatinib—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0081	0.0359	CbGpPWpGaD
Lapatinib—Cough—Varenicline—nicotine dependence	0.00805	0.0209	CcSEcCtD
Lapatinib—Arthralgia—Varenicline—nicotine dependence	0.00785	0.0204	CcSEcCtD
Lapatinib—Myalgia—Varenicline—nicotine dependence	0.00785	0.0204	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0078	0.0203	CcSEcCtD
Lapatinib—Infection—Varenicline—nicotine dependence	0.00748	0.0194	CcSEcCtD
Lapatinib—Nervous system disorder—Varenicline—nicotine dependence	0.00738	0.0192	CcSEcCtD
Lapatinib—Skin disorder—Varenicline—nicotine dependence	0.00731	0.019	CcSEcCtD
Lapatinib—Anorexia—Varenicline—nicotine dependence	0.00717	0.0187	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00686	0.0178	CcSEcCtD
Lapatinib—Insomnia—Varenicline—nicotine dependence	0.00681	0.0177	CcSEcCtD
Lapatinib—Dyspnoea—Varenicline—nicotine dependence	0.00671	0.0175	CcSEcCtD
Lapatinib—Dyspepsia—Varenicline—nicotine dependence	0.00663	0.0172	CcSEcCtD
Lapatinib—Decreased appetite—Varenicline—nicotine dependence	0.00654	0.017	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0065	0.0169	CcSEcCtD
Lapatinib—Fatigue—Varenicline—nicotine dependence	0.00649	0.0169	CcSEcCtD
Lapatinib—Constipation—Varenicline—nicotine dependence	0.00644	0.0167	CcSEcCtD
Lapatinib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00616	0.016	CcSEcCtD
Lapatinib—Abdominal pain—Varenicline—nicotine dependence	0.00595	0.0155	CcSEcCtD
Lapatinib—CYP2C8—brain—nicotine dependence	0.00567	0.0145	CbGeAlD
Lapatinib—Hypersensitivity—Varenicline—nicotine dependence	0.00555	0.0144	CcSEcCtD
Lapatinib—ABCB1—cardiovascular system—nicotine dependence	0.00554	0.0142	CbGeAlD
Lapatinib—Asthenia—Varenicline—nicotine dependence	0.0054	0.014	CcSEcCtD
Lapatinib—Pruritus—Varenicline—nicotine dependence	0.00533	0.0138	CcSEcCtD
Lapatinib—Diarrhoea—Varenicline—nicotine dependence	0.00515	0.0134	CcSEcCtD
Lapatinib—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00487	0.0216	CbGpPWpGaD
Lapatinib—Vomiting—Varenicline—nicotine dependence	0.00479	0.0124	CcSEcCtD
Lapatinib—Rash—Varenicline—nicotine dependence	0.00475	0.0123	CcSEcCtD
Lapatinib—Dermatitis—Varenicline—nicotine dependence	0.00474	0.0123	CcSEcCtD
Lapatinib—Headache—Varenicline—nicotine dependence	0.00472	0.0123	CcSEcCtD
Lapatinib—ERBB2—Signaling by NGF—FGD1—nicotine dependence	0.0047	0.0208	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—FGD1—nicotine dependence	0.00463	0.0205	CbGpPWpGaD
Lapatinib—Nausea—Varenicline—nicotine dependence	0.00447	0.0116	CcSEcCtD
Lapatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00435	0.0193	CbGpPWpGaD
Lapatinib—ABCB1—midbrain—nicotine dependence	0.00432	0.0111	CbGeAlD
Lapatinib—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0043	0.019	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00383	0.017	CbGpPWpGaD
Lapatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00377	0.0167	CbGpPWpGaD
Lapatinib—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00372	0.0165	CbGpPWpGaD
Lapatinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00353	0.0156	CbGpPWpGaD
Lapatinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00337	0.0149	CbGpPWpGaD
Lapatinib—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00332	0.0147	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00315	0.014	CbGpPWpGaD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00306	0.0136	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00273	0.0121	CbGpPWpGaD
Lapatinib—ABCB1—brain—nicotine dependence	0.00272	0.00697	CbGeAlD
Lapatinib—TAP1—Immune System—WASF2—nicotine dependence	0.00259	0.0115	CbGpPWpGaD
Lapatinib—TAP1—Immune System—WASF1—nicotine dependence	0.00248	0.011	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CYP2A7—nicotine dependence	0.00243	0.0108	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00238	0.0106	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—CYP2A7—nicotine dependence	0.00235	0.0104	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00228	0.0101	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—FGD1—nicotine dependence	0.00227	0.0101	CbGpPWpGaD
Lapatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00202	0.00897	CbGpPWpGaD
Lapatinib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.002	0.00885	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00199	0.00882	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00187	0.00831	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00185	0.0082	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00172	0.00764	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—WASF2—nicotine dependence	0.00167	0.0074	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—WASF2—nicotine dependence	0.00164	0.00729	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00164	0.00727	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00162	0.0072	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0016	0.0071	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—WASF1—nicotine dependence	0.0016	0.00709	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—WASF1—nicotine dependence	0.00158	0.00698	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00154	0.00682	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00145	0.00642	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00143	0.00634	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TAS2R16—nicotine dependence	0.00129	0.0057	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKR1B10—nicotine dependence	0.00127	0.00565	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TAS2R16—nicotine dependence	0.00127	0.00562	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKR1B10—nicotine dependence	0.00125	0.00556	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TAS2R16—nicotine dependence	0.00105	0.00467	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGD1—nicotine dependence	0.00101	0.00448	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGD1—nicotine dependence	0.000994	0.00441	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—WASF2—nicotine dependence	0.000972	0.00431	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—WASF2—nicotine dependence	0.000957	0.00424	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—WASF1—nicotine dependence	0.000931	0.00413	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000924	0.0041	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—WASF1—nicotine dependence	0.000918	0.00407	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000892	0.00395	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKR1B10—nicotine dependence	0.000878	0.00389	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000871	0.00386	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000859	0.00381	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—FGD1—nicotine dependence	0.000826	0.00366	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—WASF2—nicotine dependence	0.000806	0.00358	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—WASF1—nicotine dependence	0.000773	0.00343	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WASF2—nicotine dependence	0.000628	0.00279	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAS2R16—nicotine dependence	0.000622	0.00276	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WASF2—nicotine dependence	0.000619	0.00274	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKR1B10—nicotine dependence	0.000616	0.00273	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WASF1—nicotine dependence	0.000602	0.00267	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WASF1—nicotine dependence	0.000593	0.00263	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—OPRM1—nicotine dependence	0.000542	0.0024	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—OPRM1—nicotine dependence	0.000534	0.00237	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000516	0.00229	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGD1—nicotine dependence	0.000488	0.00216	CbGpPWpGaD
Lapatinib—EGFR—Immune System—WASF2—nicotine dependence	0.00047	0.00208	CbGpPWpGaD
Lapatinib—EGFR—Immune System—WASF1—nicotine dependence	0.00045	0.002	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—OPRM1—nicotine dependence	0.000444	0.00197	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKR1B10—nicotine dependence	0.000431	0.00191	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—DRD2—nicotine dependence	0.000392	0.00174	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—DRD2—nicotine dependence	0.000386	0.00171	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—DRD2—nicotine dependence	0.000321	0.00142	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000321	0.00142	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WASF2—nicotine dependence	0.000304	0.00135	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WASF1—nicotine dependence	0.000291	0.00129	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000278	0.00123	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—OPRM1—nicotine dependence	0.000262	0.00116	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000248	0.0011	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000242	0.00107	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.00084	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000149	0.000661	CbGpPWpGaD
